| RS2130810933 |
HGSNAT
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS2130813174 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130813187 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130813849 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130813916 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130813918 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130813950 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130814064 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130816341 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130817575 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130817608 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130817714 |
PLEC
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS2130819661 |
HGSNAT
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 73, Mucopolysaccharidosis |
| RS2130821307 |
HGSNAT
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS2130821593 |
HGSNAT
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 73, Mucopolysaccharidosis |
| RS2130822351 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130822605 |
DDHD2
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 54, Hereditary spastic paraplegia 54 |
| RS2130826217 |
ELN
|
Health Risk |
Pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS2130830261 |
ELN
|
Health Risk |
Pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS2130831990 |
TONSL
|
Health Risk |
Likely pathogenic |
Sponastrime dysplasia, Sponastrime dysplasia |
| RS2130845614 |
ADAMTS13
|
Health Risk |
Likely pathogenic |
Upshaw-Schulman syndrome, Upshaw-Schulman syndrome |
| RS2130847575 |
TONSL
|
Health Risk |
Likely pathogenic |
Sponastrime dysplasia, Sponastrime dysplasia |
| RS2130848885 |
DDHD2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 54, Hereditary spastic paraplegia 54 |
| RS2130848959 |
TONSL
|
Health Risk |
Pathogenic |
— |
| RS2130853055 |
DCLRE1C
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Severe combined immunodeficiency due to DCLRE1C deficiency |
| RS2130858031 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Cohen syndrome |
| RS2130858310 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130858335 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130858386 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130860471 |
KCNV2
|
Health Risk |
Pathogenic |
— |
| RS2130860673 |
KCNV2
|
Health Risk |
Pathogenic |
— |
| RS2130860955 |
KCNV2
|
Health Risk |
Pathogenic |
— |
| RS2130860973 |
KCNV2
|
Health Risk |
Pathogenic |
— |
| RS2130861136 |
KCNV2
|
Health Risk |
Pathogenic |
— |
| RS2130861209 |
KCNV2
|
Health Risk |
Pathogenic |
— |
| RS2130865334 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130865566 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130866580 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130866708 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130866735 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130872867 |
IFT56
|
Health Risk |
Pathogenic |
Biliary, renal |
| RS2130879011 |
DOCK8
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS2130880784 |
PLEC
|
Health Risk |
Likely pathogenic |
— |
| RS2130882939 |
GLIS3
|
Health Risk |
Likely pathogenic |
— |
| RS2130888037 |
TG
|
Health Risk |
Pathogenic |
Iodotyrosyl coupling defect, Iodotyrosyl coupling defect |
| RS2130891688 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS2130902516 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130905407 |
SLC20A2
|
Health Risk |
Likely pathogenic |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS2130918080 |
DCLRE1C
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Histiocytic medullary reticulosis |
| RS2130918298 |
VPS13B
|
Health Risk |
Pathogenic/Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130933492 |
VPS13B
|
Health Risk |
Likely pathogenic |
— |
| RS2130933596 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130933734 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130938370 |
DCLRE1C
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Severe combined immunodeficiency due to DCLRE1C deficiency |
| RS2130938733 |
KCNQ3
|
Health Risk |
Conflicting classifications of pathogenicity |
Benign neonatal seizures, Benign neonatal seizures |
| RS2130941591 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130941863 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130943393 |
DCLRE1C
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Severe combined immunodeficiency due to DCLRE1C deficiency |
| RS2130944386 |
KCNQ3
|
Health Risk |
Pathogenic |
Benign neonatal seizures, Benign neonatal seizures |
| RS2130944445 |
DCLRE1C
|
Health Risk |
Likely pathogenic |
Athabaskan severe combined immunodeficiency, Severe combined immunodeficiency due to DCLRE1C deficiency |
| RS2130956855 |
DCLRE1C
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Severe combined immunodeficiency due to DCLRE1C deficiency |
| RS2130962934 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130972411 |
VPS13B
|
Health Risk |
Pathogenic/Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130972502 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130972632 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130974126 |
DCLRE1C
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Histiocytic medullary reticulosis |
| RS2130975687 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130975930 |
SPTAN1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 5 |
| RS2130976122 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130976129 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2130983856 |
MAN1B1
|
Health Risk |
Likely pathogenic |
Rafiq syndrome, Rafiq syndrome |
| RS2130986124 |
MAN1B1
|
Health Risk |
Pathogenic |
Rafiq syndrome, Rafiq syndrome |
| RS2130987702 |
CUX1
|
Health Risk |
Likely pathogenic |
Global developmental delay with or without impaired intellectual development, Global developmental delay with or without impaired intellectual development |
| RS2130990601 |
CLN8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2130990747 |
CLN8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2131001171 |
TOR1A
|
Health Risk |
Pathogenic |
Early-onset generalized limb-onset dystonia, Early-onset generalized limb-onset dystonia |
| RS2131003180 |
SLC20A2
|
Health Risk |
Pathogenic |
— |
| RS2131003774 |
SLC20A2
|
Health Risk |
Pathogenic |
— |
| RS2131004790 |
TOR1A
|
Health Risk |
Pathogenic |
Early-onset generalized limb-onset dystonia, Early-onset generalized limb-onset dystonia |
| RS2131006757 |
SLC20A2
|
Health Risk |
Pathogenic |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS2131006903 |
SLC20A2
|
Health Risk |
Pathogenic |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS2131007486 |
TOR1A
|
Health Risk |
Pathogenic |
Early-onset generalized limb-onset dystonia, Early-onset generalized limb-onset dystonia |
| RS2131008814 |
SLC20A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2131011877 |
SPTAN1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 5 |
| RS2131012464 |
SPTAN1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2131012797 |
SPTAN1
|
Health Risk |
Likely pathogenic |
Developmental delay with or without epilepsy, Developmental and epileptic encephalopathy |
| RS2131015097 |
DNAAF11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 19, Primary ciliary dyskinesia 19 |
| RS2131023674 |
AGPAT2
|
Health Risk |
Likely pathogenic |
Congenital generalized lipodystrophy type 1, Congenital generalized lipodystrophy type 1 |
| RS2131023956 |
AGPAT2
|
Health Risk |
Pathogenic |
Congenital generalized lipodystrophy type 1, Congenital generalized lipodystrophy type 1 |
| RS2131026813 |
DCLRE1C
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Histiocytic medullary reticulosis |
| RS2131027694 |
DCLRE1C
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Histiocytic medullary reticulosis |
| RS2131028639 |
SPTAN1
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2131029946 |
VPS13A
|
Health Risk |
Likely pathogenic |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS2131030007 |
VPS13A
|
Health Risk |
Likely pathogenic |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS2131030113 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131030226 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131030277 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131030804 |
SPTAN1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 5 |
| RS2131032901 |
LHX3
|
Health Risk |
Likely pathogenic |
Non-acquired combined pituitary hormone deficiency with spine abnormalities, Non-acquired combined pituitary hormone deficiency with spine abnormalities |
| RS2131032918 |
LHX3
|
Health Risk |
Pathogenic |
— |